Discover our Integrated Symposium at ESCMID Global 2026
Turning insight into impact: Optimising bloodstream infection diagnostics with performance metrics
20 April | 13:30–15:30 | Hall A1–3
Widespread inconsistencies and delays in sepsis and bloodstream infection diagnostics remain a critical challenge. This symposium explores the current status of diagnostic pathways across Europe and the clinical challenges posed by delays and suboptimal processes while highlighting how performance metrics and data can help close these gaps.
Meet the speakers
Dr Christian Scheer, University Medicine Greifswald, Germany
Microbiological diagnostic capacity for sepsis: insights from the European Sepsis Care survey
Since 2012, Dr Scheer has been part of the sepsis research group and the award‑winning quality‑improvement initiative “Sepsisdialog.” His work focuses on sepsis quality improvement, and he has contributed to multiple national research efforts, including the German National Pandemic Cohort Network. Dr Scheer is also a member of the European Sepsis Alliance working group and serves as Principal Investigator of the European Sepsis Care Survey project.
Dr Climent Casals, Hospital Clínic de Barcelona, Spain
Impact of delayed diagnostics: the role of clinical microbiology
With advanced training from the London School of Hygiene and Tropical Medicine and a PhD from the University of Oxford, Dr Climent Casals has led influential research in proteomics and systems biology to advance biomarker discovery in infectious diseases.
Prof Brigitte Lamy, Université Sorbonne Paris Nord / APHP, France
From key performance indicators to combined indicators to improve blood culture practices: the French experience
Trained in Tours, Lyon and at Imperial College London, she works across diagnostics, teaching and research within the IAME group. Her expertise focuses on bloodstream infections and rapid diagnostics. Prof Lamy serves as the French Society for Microbiology’s blood culture referee and chairs the ESCMID Study Group on Bloodstream Infection, Endocarditis and Sepsis (ESGBIES). She also leads key national projects to improve BSI diagnosis in France.
Prof Fabio Arena, University of Perugia / Perugia Hospital, Italy
Informatics for monitoring key performance indicators and continuous improvement: the Italian experience
A double specialist in infectious diseases and microbiology, Prof Arena focuses on antimicrobial resistance, new antimicrobial agents, and innovative diagnostic solutions—work that has led to international patents and several competitive research grants. He is also active in national scientific societies and serves as Editor‑in‑Chief of GImPIOS journal.
ESCMID-appointed Chair is:
Dr Amy Mathers
University of Virginia
Division of Infectious Diseases & International Health
Charlottesville
United States
BD-appointed Chair:
Gioia Silvana Babini
Director
Medical Affairs EMEA
BD Diagnostic Solutions
Catania, Italy
Waters™ Advanced Diagnostics, formerly BD Diagnostic Solutions at ESCMID GLOBAL 2026
We are delighted to celebrate our first ESCMID under our new identity and continue advancing diagnostic excellence together, with you.
This year, discover how Waters™ Advanced Diagnostics is redefining the future of diagnostics through innovation.
Click on the link below to learn more about how we’re raising the bar on what’s possible in diagnostic excellence – from breakthrough product launches to fresh opportunities for hands‑on learning on our on-booth innovation arena.
We’re looking forward to welcoming you at booth C60!
